Pigmentation
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Women aged 18-50 years; 2. Those who have the intention to improve the skin color and skin quality of the nipple areola; 3. The patient agrees to participate in the study and signs the informed consent.
Exclusion criteria
Exclusion criteria: 1. Pregnant or lactating patients; 2. Those who have a pacemaker or internal defibrillator in their body, or implanted other metal devices; 3. Skin malignancies or precancerous lesions; Have a history of serious underlying diseases, such as heart disease, diabetes, coagulopathy, epilepsy, etc.; 4. Patients with ruptured, infected or recurrent herpes simplex in the treatment area; 5. Patients with sensory impairments such as nerve damage; 6. Patients with scar constitution, allergic constitution, anesthetic allergy and high psychological expectation; 7. Patients with breast fillings, thread burying, chemical peels and other treatments in the past 3 months; 8. Taking isotretinoin in the past 6 months (whether it is A tretinoin drug); 9. Patients who were not considered suitable to participate in this trial by investigators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 3D imaging analysis system;Improvement of nipple and areola color comparison card color code;Evaluation of the therapeutic effect of Seeman's quartet grading method; | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual analogue scale score for pain;Patient satisfaction evaluation ; | — |
Countries
China
Contacts
The First A?liated Hospital of the Air Force Medical University